InvestorsHub Logo

BIGANDBAD

06/15/17 8:38 PM

#9401 RE: VortMax #9399

Drug sucks for liver cancer ! Bayer knows that too !

VortMax

06/15/17 8:39 PM

#9402 RE: VortMax #9399

and the DCTH overall survival median will keep moving up as those who have complete reponse live cancer free and a long time which can only be a projection now. Certainly going to see overall survival over 2 years with DCTH.

DCTH beats Stivarga hands down, so Bayer will want DCTH

Rymankoly

06/15/17 9:23 PM

#9415 RE: VortMax #9399

You do know that DCTH is only making the delivery system and not the drug?
Drug is generic by now as you know.....

carsm

06/16/17 6:15 AM

#9436 RE: VortMax #9399

Great post, love the take over article

VortMax

06/16/17 11:49 AM

#9484 RE: VortMax #9399

anyone have any comments questions or concerns about just how good DCTH tech is at treating liver cancers vs the market standard today?

VortMax

06/16/17 5:32 PM

#9564 RE: VortMax #9399

Takeover cometh free to run now. Company will have to be a pr machine putting out data and moving the stock north. Market cap is so small

ace1mc

06/19/17 12:04 PM

#10002 RE: VortMax #9399

Could this go up like last years one stock that went from $1.00 all the way up to $50.00 a share in one week.

SOUTHGAS

06/20/17 12:00 AM

#10337 RE: VortMax #9399

What is this stock a QB?

VortMax

06/20/17 12:31 AM

#10343 RE: VortMax #9399

More i think about it the more valuation increases. The tech parlays into crc downstream. Widespread adoption. A tech play and pharma play at the same time.

VortMax

06/20/17 10:56 AM

#10543 RE: VortMax #9399

good reading here for newbs....smashes current standard for treatment

VortMax

06/22/17 12:16 PM

#12394 RE: VortMax #9399

Trump$ FDA